|
You are here Biopharmaceutical/
Genomic
Glossary
homepage/Search > Index> A-Z index pharmaceutical glossaries
& taxonomies
Pharmaceutical Glossaries
& taxonomies A-Z Index
Evolving Terminologies for Emerging Technologies
Comments? Questions?
Revisions? Mary Chitty mchitty@healthtech.com
Last revised May 07, 2010
View a Printer-Friendly Version of this Web Page!
New Page 1
Until this gets into
a database there is no A-Z list of terms. Try these "maps" 21st
century Drug Discovery & Development Site Map Informatics
Site Map Technologies
Site Map Biology
& Chemistry Site Map Use Find on your browser or the Home Page search engine
About
Biopharmaceutical glossaries & taxonomies
Acronyms
Algorithms & data
management - pharmaceutical
Alliances - pharmaceutical
Applications biotechnology &
pharmaceutical
Applications Pharmaceutical Site Map
Assays & screening - pharmaceutical
A to Z index
Basic genetics
& genomics -- What's the difference?
Bibliography - pharmaceutical
Bioinformatics
Biologics: antibodies, cell therapies, protein therapeutics & vaccines
Biology - pharmaceutical Site map
Biology molecular & cellular overview
Biomarkers
Biomaterials & bioengineering
Biomolecules - pharmaceutical
Bioprocessing pharmaceutical
Biotechnology & pharmaceutical applications
overview
Business of biopharmaceuticals
Cancer diagnostics, genomics, prognostics & therapeutics
Cardiovascular: therapeutic areas
Cell technologies & therapies - pharmaceutical
Chemoinformatics
Chemistry medicinal & pharmaceutical
Chemistry
Site
map
CHI biopharmaceutical glossary
Chromatography
& electrophoresis
Clinical & medical genomics
& proteomics
Clinical trials
Central Nervous System CNS & neurology:
therapeutic areas
Combinatorial libraries and synthesis
Computers & computing for biopharmaceuticals
Concise biopharmaceutical glossary
Contact Biopharmaceutical Glossaries & Taxonomies
DNA
Databases
& software -- biopharmaceutical directory
Diabetes & immunology :
therapeutic areas
Drug approvals: Drug, device & diagnostics approvals
& clinical trials See Clinical trials
Regulatory Affairs
Drug delivery & formulation
Drug
discovery & development
Drug
discovery & development overview
Drug discovery & development Site Map
Drug Discovery Twenty First Century map
Drug safety, pharmacovigilance, post marketing surveillance &
toxicology/toxicogenomics
Drug targets & disease targets
Ethics
- pharmaceutical
Expression - genetic, genomic, protein & proteomic
FAQ/Tips
Finance and pharmaceuticals
Functional
genomics
Gene
amplification & PCR
Gene categories
Gene definitions
Genomic & proteomic manipulation & disruption for
pharmaceuticals, including RNAinterference
Genetic & genomic testing
Genetic
variations & SNPs
Genomic biology for pharmaceuticals overview
Genomics categories
Genomics
Glossaries -- biopharmaceutical methodology
Glycosciences
How terms were chosen and defined
How to look for other unfamiliar terms
Imaging
Immunology &
autoimmune : therapeutic areas
In silico &
molecular modeling
Infectious diseases :
therapeutic areas
Inflammation :
therapeutic areas
Information
management & interpretation for pharmaceuticals
Informatics -- pharmaceutical Site map
Informatics for pharmaceuticals overview
Information overload
Intellectual property & legal for
biopharmaceuticals
IT infrastructure: Hardware & software
Journals for
biopharmaceuticals links
Labels, signaling & detection
Libraries,
combinatorial & synthesis
Maps, genetic & genomic
Mass spectrometry for biopharmaceuticals
Medicinal & Pharmaceutical Chemistry
Metabolic profiling, metabolic engineering
Methodologies for these glossaries
Microarray & protein chip categories
Microarrays & protein chips
Microscopy for biopharmaceuticals
Miniaturization &
nanoscience
Model
& other organisms
Molecular & in
silico modeling
Molecular & predictive diagnostics
Molecular Medicine & Predictive
Biomedicine
Molecular imaging
Nanoscience &
miniaturization
Newest biopharmaceutical definitions
Nomenclature,
genes, proteins & species
NMR synchrotrons & x-ray crystallography
-Omes &
-omics
Oncology
& cancer: diagnostics, genetics, genomics, prognostics & therapeutic areas
Ontologies & taxonomies
for life sciences & pharmaceuticals
Patient resources
PCR & Gene amplification
Pharmaceutical & biotechnology overview
Pharmaceutical & Medicinal Chemistry
Pharmaceutical
biology & chemistry
Personalized Medicine &
Pharmacogenomics
Phylogenomics
Privacy policy
Protein categories
Protein
structures for biopharmaceuticals
Proteins for biopharmaceuticals
Proteomics categories
Proteomics
Research & pharmaceuticals
Regulatory Affairs
RNA
RNAinterference
SNPs & other genetic variations
Sequences,
DNA & beyond
Sequencing for biopharmaceuticals
Site Map - Biopharmaceuticals
Stem cells
Structural
genomics
Targets drug & disease-- pharmaceutical
Technologies -- biopharmaceutical Site map
Technologies for pharmaceuticals overview
Therapeutic areas: cancer & oncology, cardiovascular, CNS & neurology,
Immunology, Infectious diseases, Inflammation
Tips/FAQ for these glossaries
Ultrasensitivity
and biopharmaceuticals
Roger Brent said in his opening
remarks for the 2000 After the Genome meeting in Jackson Hole Wyoming "current
efforts to come to grips with genomic information often resemble computer-savvy
library science, where the most important issues concern categories,
classification schemes and information retrieval…What we would actually
like to achieve, however, is a predictive understanding of biological
function. The goal here is a true computational biology that will be able
to make functional predictions from available genomic data [italics added]
http://www.atgx.org/info_gruber.html CHI
glossary
|
